Lu AF82422 is really a mAb tested as Harmless and effectively tolerated in the section I trial in nutritious topics and patients with PD (NCT03611569). A stage II study investigating the safety and efficacy in clients https://victorrzgx683578.getblogs.net/62743051/new-step-by-step-map-for-parkinson-s-vs-multiple-system-atrophy